call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Colorectal Cancer Screening And Diagnostic Market
Inquire Before Buying Request for Sample

Colorectal Cancer Screening And Diagnostic Market

Home Healthcare And Pharmaceutical Colorectal Cancer Screening And Diagnostic Market

Colorectal Cancer Screening and Diagnostic Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Screening Method (Fecal Occult Blood Tests (FOBT), Colonoscopy, Sigmoidoscopy, CT Colonography (Virtual Colonoscopy), Stool DNA Testing); By Diagnostic Tools (Biopsy, Blood Tests, Imaging Techniques); By End User (Hospitals & Clinics, Diagnostic Centers, Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: January 2024
  • Report ID: BWC24055
  • Available Format: PDF
  • Page: 400

Report Overview

The rising incidence of colorectal cancer and a growing focus on the treatment of the disease and management of spiraling healthcare expenditures are expected to boost the growth of Global Colorectal Cancer Screening and Diagnostic Market during the forecast period between 2024 and 2030.

Global Colorectal Cancer Screening and Diagnostic Market - Industry Trends & Forecast Report, 2030

The Global Colorectal Cancer Screening and Diagnostic Market size was estimated to be worth USD 15.97 billion in 2023. During the forecast period between 2024 and 2030, the Global Colorectal Cancer Screening and Diagnostic Market size is projected to grow at a CAGR of 8.95%, reaching a value of USD 26.71 billion by 2030. Major growth factors for the Global Colorectal Cancer Screening and Diagnostic Market include the rising prevalence of colorectal cancer and rising government programs and schemes aimed at promoting cancer screening and early diagnosis. Moreover, rising private-public investments toward the launch of new and advanced products in cancer screening and diagnostics is anticipated to proliferate the global colorectal cancer screening and diagnostic market during the period in analysis.

Colorectal Cancer Screening and Diagnostic Market

Colorectal Cancer Screening and Diagnostic – Overview

The Centers for Disease Control and Prevention defines colorectal cancer as an uncontrollably growing tumor of the colon or rectum. Pfizer claims that generally, environmental exposures, such as a high-fat, low-fiber diet, alcohol use, and tobacco use, which happened decades before a patient's diagnosis, account for about 90% of colorectal cancer cases. Dietary metabolites have lately been linked by researchers to either a procarcinogenic or protective environment in the colon. Screening used to check for colorectal cancer include fecal occult blood tests, sigmoidoscopy, colonoscopy, virtual colonoscopy, and DNA stool tests are the available methods for screening for colorectal cancer. The most often used method is colonoscopy.

Global Colorectal Cancer Screening and Diagnostic Market

Growth Drivers

Expanding Research and Development Programs

The rising burden of colorectal cancer is prompting governments across the regions as well as industry players to significantly invest in the research and development programs surrounding colorectal screening and diagnosis. For instance, a new study published in the journal BMJ Oncology reports researchers developed a new blood test that is capable of detecting 93% of stage 1 cancers in men and 84% in women. Such developments are anticipated to reduce the rise effects associated with colorectal cancer screening and diagnostics, eventually boosting the number of diagnosis.

Challenges

Negative Effects of Colonoscopy

With the rising incidences of colorectal cancer, the demand for its screening and diagnostic is also increasing. However, negative effects associated with these tests may limit the patients to seek these procedures limiting the number of cancer diagnosis. For instance, colonoscopy may lead to certain complications such as bleeding and perforation. According to research on screening colonoscopies, about 3 out of every 10,000 operations result in perforation. About 15 out of every 10,000 surgeries result in bleeding, as reported by National Institutes of Health. Such complications in screening and diagnosis may restrict the growth of the Global Colorectal Cancer Screening and Diagnostic Market.

Impact of Escalating Geopolitical Tensions on Global Colorectal Cancer Screening and Diagnostic Market

The escalating geopolitical tensions are disrupting the growth of the global colorectal cancer screening and diagnostic market. For instance, Ukraine is a leading medical tourism destination for the diagnosis and treatment of cancer. However, Russia's invasion of Ukraine and the outbreak of war between the two countries led to the inaccessibility of healthcare services. According to a paper published in the National Center for Biotechnology Information, the conflict led to the displacement of patients to safer regions, particularly Europe, which overburdened the healthcare sector in these countries due to the large number of refugees. As a result, the inaccessibility of cancer screening and diagnosis hindered overall global market growth.

Global Colorectal Cancer Screening and Diagnostic Market

Segmental Coverage

Global Colorectal Cancer Screening and Diagnostic Market – By Screening Method

Based on screening method, the Global Colorectal Cancer Screening and Diagnostic Market is segmented into Fecal Occult Blood Tests (FOBT), Colonoscopy, Sigmoidoscopy, CT Colonography (Virtual Colonoscopy), and Stool DNA Testing. The colonoscopy segment accounts for the highest share in the Global Colorectal Cancer Screening and Diagnostic Market. Colonoscopy offers high accuracy, reportedly at 95%, which makes it a preferred choice among medical professionals for the screening and diagnosis of colorectal cancer. The stool-based segment is anticipated to witness growth at a high CAGR during the forecast period owing to its 92% sensitivity rate in detecting colorectal cancer.

Global Colorectal Cancer Screening and Diagnostic Market – By Diagnostic Tool

Based on diagnostic tool, the Global Colorectal Cancer Screening and Diagnostic Market is divided into biopsy, blood tests, and imaging techniques segments. The imaging techniques segment holds the largest share of the Global Colorectal Cancer Screening and Diagnostic Market. Hospitals and diagnostic centers increasingly utilize CT and MR (magnetic resonance) colonography to screen for significant growths, such as polyps, within the rectum and colon to diagnose colorectal cancer.

Global Colorectal Cancer Screening and Diagnostic Market – By End User

Based on end user, the Global Colorectal Cancer Screening and Diagnostic Market is segmented into hospitals & clinics, diagnostic centers, and research institutes. The hospitals & clinics segment accounts for the highest market share owing to the high number of hospitals and the increasing number of awareness campaigns. Additionally, favorable reimbursement policies and insurance coverage also support the growth of the hospital segment in the market. The diagnostic centers are predicted to register growth at a substantial CAGR during the forecast period. The growth of diagnostics segment is attributed to the rising number of colonoscopies for colorectal cancer screening.

Colorectal Cancer Screening and Diagnostic Market Size

Global Colorectal Cancer Screening and Diagnostic Market – By Region

The in-depth research report on the Global Colorectal Cancer Screening and Diagnostic Market covers the market in a number of major countries across five regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Colorectal Cancer Screening and Diagnostic Market owing to the rising incidences of the disease. According to estimates by the American Society of Clinical Oncology, colorectal cancer is the fourth most diagnosed cancer in the United States, with an estimated 52,550 deaths in 2023. Colorectal cancer screenings are generally recommended for people over the age of 50. However, the Washington Post reports that this cancer type is increasingly gaining prevalence among American youth, which is anticipated to drive the demand for colorectal cancer screening and diagnosis in North America during the forecast period.

Colorectal Cancer Screening and Diagnostic Market Share

Competitive Landscape

Major players operating in the Global Colorectal Cancer Screening and Diagnostic Market include Epigenomics Inc., Exact Sciences Corporation, Eiken Chemical Co. Ltd., Polymedco Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Sysmex Corporation, Olympus Corporation, Biocept Inc., and Pathway Genomics Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In November 2023 – Geneoscopy, a biotechnology company, and Labcorp, a lab diagnostic service provider, signed a multi-year agreement for the distribution of the non-invasive multi-target stool RNA (mt-sRNA) test for colorectal cancer screening.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2023

Base Year – 2023

Estimated Year – 2024

Forecast Period– 2024–2030

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Screening Methods, Diagnostic Tools, End Users, Region

Key Players

Epigenomics Inc., Exact Sciences Corporation, Eiken Chemical Co. Ltd, Polymedco Inc, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Sysmex Corporation, Olympus Corporation, Biocept Inc., Pathway Genomics Corporation

 

By Screening Method

  • Fecal Occult Blood Tests (FOBT)

  • Colonoscopy

  • Sigmoidoscopy

  • CT Colonography (Virtual Colonoscopy)

  • Stool DNA Testing

By Diagnostic Tool

  • Biopsy

  • Blood Tests

  • Imaging Techniques

By End User

  • Hospitals & Clinics

  • Diagnostic Centers

  • Research Institutes

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America (LATAM)

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3.  Global Colorectal Cancer Screening and Diagnostic Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing Incidence of Colorectal Cancer
        2. Growing Healthcare Expenditure
      2. Restraints
        1. High Costs Associated with Colorectal Cancer Screening and Diagnostic Procedures
        2. Lack of Awareness about Colorectal Cancer
      3. Opportunities
        1. Government Initiatives and Awareness Campaigns
        2. Integration of Telemedicine and Digital Health Solutions
      4. Challenges
        1. Data Security and Privacy Concerns
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Colorectal Cancer Screening and Diagnostic Market Overview
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share and Forecast
      1. By Screening Method
        1. Fecal Occult Blood Tests (FOBT)
        2. Colonoscopy
        3. Sigmoidoscopy
        4. CT Colonography (Virtual Colonoscopy)
        5. Stool DNA Testing
      2. By Diagnostic Tool
        1. Biopsy
        2. Blood Tests
        3. Imaging Techniques
      3. By End User
        1. Hospitals and Clinics
        2. Diagnostic Centers
        3. Research Institutes
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Colorectal Cancer Screening and Diagnostic Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Screening Method
      2. By Diagnostic Tool
      3. By End User
      4. By Country
        1. United States
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        2. Canada
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
  6. Europe Colorectal Cancer Screening and Diagnostic Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Screening Method
      2. By Diagnostic Tool
      3. By End User
      4. By Country
        1. Germany
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        2. United Kingdom
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        3. Italy
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        4. France
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        5. Spain
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        6. Belgium
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        7. Russia
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        8. The Netherlands
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        9. Rest of Europe
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
  7. Asia Pacific Colorectal Cancer Screening and Diagnostic Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Screening Method
      2. By Diagnostic Tool
      3. By End User
      4. By Country
        1. China
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        2. India
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        3. Japan
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        4. South Korea
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        5. Australia & New Zealand
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        6. Indonesia
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        7. Malaysia
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        8. Singapore
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        9. Vietnam
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        10. Rest of APAC
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
  8. Latin America Colorectal Cancer Screening and Diagnostic Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Screening Method
      2. By Diagnostic Tool
      3. By End User
      4. By Country
        1. Brazil
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        2. Mexico
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        3. Argentina
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        4. Peru
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        5. Rest of LATAM
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
  9. Middle East & Africa Colorectal Cancer Screening and Diagnostic Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Screening Method
      2. By Diagnostic Tool
      3. By End User
      4. By Country
        1. Saudi Arabia
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        2. UAE
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        3. Qatar
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        4. Kuwait
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        5. South Africa
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        6. Nigeria
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        7. Algeria
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
        8. Rest of MEA
          1. By Screening Method
          2. By Diagnostic Tool
          3. By End User
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Colorectal Cancer Screening and Diagnostic Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Escalating Geopolitical Tensions on Global Colorectal Cancer Screening and Diagnostic Market
  12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Epigenomics Inc.
    2. Exact Sciences Corporation
    3. Eiken Chemical Co. Ltd
    4. Polymedco Inc
    5. F. Hoffmann-La Roche AG
    6. Siemens Healthineers AG
    7. Sysmex Corporation
    8. Olympus Corporation
    9. Biocept Inc.
    10. Pathway Genomics Corporation
    11. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

 

Figure 1       Global Colorectal Cancer Screening and Diagnostic Segmentation

Figure 2       Global Colorectal Cancer Screening and Diagnostic Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       Global Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 5       Global Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 6       Global Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 7       Global Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 8       Global Colorectal Cancer Screening and Diagnostic Market Share, By Region, By Value, 2019–2030

Figure 9       North America Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 10     North America Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 11     North America Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 12     North America Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 13     North America Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Figure 14     United States Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 15     United States Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 16     United States Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 17     United States Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 18     Canada Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 19     Canada Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 20     Canada Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 21     Canada Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 22     Europe Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 23     Europe Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 24     Europe Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 25     Europe Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 26     Europe Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Figure 27     Germany Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 28     Germany Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 29     Germany Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 30     Germany Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 31     United Kingdom Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 32     United Kingdom Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 33     United Kingdom Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 34     United Kingdom Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 35     Italy Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 36     Italy Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 37     Italy Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 38     Italy Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 39     France Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 40     France Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 41     France Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 42     France Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 43     Spain Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 44     Spain Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 45     Spain Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 46     Spain Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 47     Belgium Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 48     Belgium Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 49     Belgium Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 50     Belgium Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 51     Russia Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 52     Russia Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 53     Russia Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 54     Russia Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 55     The Netherlands Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 56     The Netherlands Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 57     The Netherlands Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 58     The Netherlands Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 59     Rest of Europe Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 60     Rest of Europe Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 61     Rest of Europe Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 62     Rest of Europe Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 63     Asia Pacific Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 64     Asia Pacific Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 65     Asia Pacific Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 66     Asia Pacific Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 67     Asia Pacific Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Figure 68     China Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 69     China Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 70     China Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 71     China Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 72     India Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 73     India Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 74     India Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 75     India Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 76     Japan Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 77     Japan Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 78     Japan Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 79     Japan Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 80     South Korea Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 81     South Korea Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 82     South Korea Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 83     South Korea Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 84     Australia & New Zealand Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 85     Australia & New Zealand Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 86     Australia & New Zealand Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 87     Australia & New Zealand Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 88     Indonesia Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 89     Indonesia Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 90     Indonesia Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 91     Indonesia Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 92     Malaysia Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 93     Malaysia Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 94     Malaysia Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 95     Malaysia Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 96     Singapore Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 97     Singapore Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 98     Singapore Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 99     Singapore Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 100   Vietnam Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 101   Vietnam Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 102   Vietnam Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 103   Vietnam Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 104   Rest of APAC Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 105   Rest of APAC Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 106   Rest of APAC Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 107   Rest of APAC Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 108   Latin America Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 109   Latin America Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 110   Latin America Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 111   Latin America Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 112   Latin America Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Figure 113   Brazil Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 114   Brazil Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 115   Brazil Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 116   Brazil Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 117   Mexico Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 118   Mexico Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 119   Mexico Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 120   Mexico Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 121   Argentina Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 122   Argentina Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 123   Argentina Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 124   Argentina Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 125   Peru Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 126   Peru Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 127   Peru Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 128   Peru Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 129   Rest of LATAM Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 130   Rest of LATAM Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 131   Rest of LATAM Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 132   Rest of LATAM Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 133   Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 134   Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 135   Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 136   Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 137   Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Figure 138   Saudi Arabia Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 139   Saudi Arabia Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 140   Saudi Arabia Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 141   Saudi Arabia Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 142   UAE Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 143   UAE Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 144   UAE Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 145   UAE Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 146   Qatar Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 147   Qatar Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 148   Qatar Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 149   Qatar Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 150   Kuwait Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 151   Kuwait Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 152   Kuwait Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 153   Kuwait Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 154   South Africa Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 155   South Africa Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 156   South Africa Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 157   South Africa Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 158   Nigeria Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 159   Nigeria Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 160   Nigeria Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 161   Nigeria Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 162   Algeria Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 163   Algeria Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 164   Algeria Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 165   Algeria Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Figure 166   Rest of MEA Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Figure 167   Rest of MEA Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Figure 168   Rest of MEA Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Figure 169   Rest of MEA Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

 

List of Tables

 

Table 1        Global Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 2        Global Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 3        Global Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 4        Global Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 5        Global Colorectal Cancer Screening and Diagnostic Market Share, By Region, By Value, 2019–2030

Table 6        North America Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 7        North America Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 8        North America Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 9        North America Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 10      North America Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Table 11      United States Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 12      United States Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 13      United States Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 14      United States Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 15      Canada Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 16      Canada Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 17      Canada Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 18      Canada Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 19      Europe Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 20      Europe Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 21      Europe Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 22      Europe Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 23      Europe Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Table 24      Germany Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 25      Germany Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 26      Germany Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 27      Germany Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 28      United Kingdom Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 29      United Kingdom Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 30      United Kingdom Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 31      United Kingdom Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 32      Italy Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 33      Italy Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 34      Italy Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 35      Italy Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 36      France Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 37      France Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 38      France Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 39      France Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 40      Spain Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 41      Spain Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 42      Spain Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 43      Spain Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 44      Belgium Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 45      Belgium Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 46      Belgium Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 47      Belgium Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 48      Russia Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 49      Russia Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 50      Russia Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 51      Russia Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 52      The Netherlands Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 53      The Netherlands Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 54      The Netherlands Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 55      The Netherlands Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 56      Rest of Europe Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 57      Rest of Europe Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 58      Rest of Europe Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 59      Rest of Europe Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 60      Asia Pacific Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 61      Asia Pacific Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 62      Asia Pacific Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 63      Asia Pacific Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 64      Asia Pacific Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Table 65      China Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 66      China Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 67      China Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 68      China Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 69      India Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 70      India Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 71      India Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 72      India Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 73      Japan Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 74      Japan Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 75      Japan Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 76      Japan Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 77      South Korea Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 78      South Korea Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 79      South Korea Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 80      South Korea Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 81      Australia & New Zealand Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 82      Australia & New Zealand Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 83      Australia & New Zealand Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 84      Australia & New Zealand Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 85      Indonesia Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 86      Indonesia Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 87      Indonesia Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 88      Indonesia Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 89      Malaysia Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 90      Malaysia Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 91      Malaysia Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 92      Malaysia Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 93      Singapore Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 94      Singapore Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 95      Singapore Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 96      Singapore Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 97      Vietnam Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 98      Vietnam Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 99      Vietnam Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 100    Vietnam Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 101    Rest of APAC Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 102    Rest of APAC Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 103    Rest of APAC Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 104    Rest of APAC Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 105    Latin America Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 106    Latin America Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 107    Latin America Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 108    Latin America Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 109    Latin America Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Table 110    Brazil Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 111    Brazil Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 112    Brazil Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 113    Brazil Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 114    Mexico Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 115    Mexico Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 116    Mexico Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 117    Mexico Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 118    Argentina Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 119    Argentina Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 120    Argentina Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 121    Argentina Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 122    Peru Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 123    Peru Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 124    Peru Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 125    Peru Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 126    Rest of LATAM Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 127    Rest of LATAM Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 128    Rest of LATAM Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 129    Rest of LATAM Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 130    Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 131    Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 132    Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 133    Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 134    Middle East and Africa Colorectal Cancer Screening and Diagnostic Market Share, By Country, By Value, 2019–2030

Table 135    Saudi Arabia Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 136    Saudi Arabia Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 137    Saudi Arabia Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 138    Saudi Arabia Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 139    UAE Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 140    UAE Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 141    UAE Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 142    UAE Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 143    Qatar Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 144    Qatar Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 145    Qatar Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 146    Qatar Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 147    Kuwait Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 148    Kuwait Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 149    Kuwait Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 150    Kuwait Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 151    South Africa Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 152    South Africa Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 153    South Africa Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 154    South Africa Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 155    Nigeria Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 156    Nigeria Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 157    Nigeria Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 158    Nigeria Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 159    Algeria Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 160    Algeria Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 161    Algeria Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 162    Algeria Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 163    Rest of MEA Colorectal Cancer Screening and Diagnostic Market Size, By Value (USD Billion), 2019–2030

Table 164    Rest of MEA Colorectal Cancer Screening and Diagnostic Market Share, By Screening Method, By Value, 2019–2030

Table 165    Rest of MEA Colorectal Cancer Screening and Diagnostic Market Share, By Diagnostic Tool, By Value, 2019–2030

Table 166    Rest of MEA Colorectal Cancer Screening and Diagnostic Market Share, By End User, By Value, 2019–2030

Table 167    Epigenomics Inc. Company Overview

Table 168    Epigenomics Inc. Financial Overview

Table 169    Exact Sciences Corporation Company Overview

Table 170    Exact Sciences Corporation Financial Overview

Table 171    Eiken Chemical Co. Ltd Company Overview

Table 172    Eiken Chemical Co. Ltd Financial Overview

Table 173    Polymedco Inc Company Overview

Table 174    Polymedco Inc Financial Overview

Table 175    F. Hoffmann-La Roche AG Company Overview

Table 176    F. Hoffmann-La Roche AG Financial Overview

Table 177    Siemens Healthineers AG Company Overview

Table 178    Siemens Healthineers AG Financial Overview

Table 179    Sysmex Corporation Company Overview

Table 180    Sysmex Corporation Financial Overview

Table 181    Olympus Corporation Company Overview

Table 182    Olympus Corporation Financial Overview

Table 183    Biocept Inc. Company Overview

Table 184    Biocept Inc. Financial Overview

Table 185    Pathway Genomics Corporation Company Overview

Table 186    Pathway Genomics Corporation Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global Colorectal Cancer Screening and Diagnostic Market size was estimated at USD 15.97 billion in 2023.
Ans: Global Colorectal Cancer Screening and Diagnostic Market size is expected to grow at a CAGR of 8.95% during the forecast period between 2024 and 2030.
Ans: Global Colorectal Cancer Screening and Diagnostic Market size is forecast to reach a value of USD 26.71 billion by 2030.
Ans: Major factors driving the growth of the Global Colorectal Cancer Screening and Diagnostic Market include rising incidences of colorectal cancer and growing healthcare expenditure.
Ans: Asia Pacific is expected to grow at the fastest CAGR in the Global Colorectal Cancer Screening and Diagnostic Market during the forecast period between 2024 and 2030.
Ans: The colonoscopy segment is expected to grow at the highest CAGR in the Global Colorectal Cancer Screening and Diagnostic Market during the forecast period between 2024 and 2030.
Ans: The hospital and clinic segment holds the highest market share in the Global Colorectal Cancer Screening and Diagnostic Market by end user.
Ans: Key players in the Global Colorectal Cancer Screening and Diagnostic Market include Epigenomics Inc., Exact Sciences Corporation, Eiken Chemical Co. Ltd, Polymedco Inc, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Sysmex Corporation, Olympus Corporation, Biocept Inc., and Pathway Genomics Corporation. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1732242289)
}